📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells (2021)

First Author: Broadbent L

Attributed to: Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.08.17.456707

Publication URI: http://dx.doi.org/10.1101/2021.08.17.456707

Type: Preprint